๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chennai
Clinical trial register · India

Clinical Trials in Chennai

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca15 Eli Lilly and Company10 Novartis Pharmaceuticals5 Janssen Research & Development, LLC4 Bristol-Myers Squibb4
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
89 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
NCT06996353Refractive Errors
London Vision Clinic
Observational
150
Chandigarh, Chennai
2025-05-26
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370Heart Failure
Boehringer Ingelheim
Phase 3
4,200
Aurangabad, Bangalore, Bikaner, Chennai, Kochi, Kolkata, Nashik, New Delhi
2025-05-20
Recruiting
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
NCT06924021Age-Related Macular Degeneration
University of Wisconsin, Madison
Observational
1,000
Chennai
2025-05-12
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company
Phase 3
700
Ahmedabad, Aurangabad, Chennai, Mumbai, Namakkal, Patna, Pune, Thalassery
2025-03-27
Active, closed
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
NCT06726265Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Immutep S.A.S.
Phase 3
756
Bangalore, Bhubaneswar, Chennai, Kolkata, New Delhi, Thane, Thiruvananthapuram, Varanasi
2025-03-21
Recruiting
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
NCT07058935Valve Disease, Heart
National Heart Centre Singapore
Observational
150
Chennai
2025-03-17
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
4,000
Bengaluru, Chennai, Vellore
2025-03-01
Recruiting
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (โ‰ฅ18 Years) Primary IgA Nephropathy?
NCT06676384IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis, IGA Glomerulonephritis
Christian Medical College, Vellore, India
Phase 4
585
Nadiฤd, Mysuru, Udupi, Mumbai, Delhi, Bhubaneswar, Puducherry, Chennai
2025-02-15
Recruiting
A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
NCT06587035Dwarfism, Pituitary
Pfizer
Observational
50
Bengaluru, Chennai, Coimbatore, Madurai
2025-01-30
Recruiting
Shortened Regimen for Drug-susceptible TB in Children
NCT06253715Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
Johns Hopkins University
Phase 3
860
Chennai, Pune
2025-01-15
Active, closed
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
NCT06317051HIV Infections, Weight Gain
Kirby Institute
Phase 3
300
Chennai
2024-12-16
Recruiting
ICU-related Out of Pocket Expenses (ICOPE)
NCT07439692Cost of ICU, Out of Pocket Expenses
Nat Intensive Care Surveillance - MORU
Observational
354
Mysore, Kochi, Pune, New Delhi, Chennai
2024-12-01
Active, closed
Cofilin-2 (rs80358250) and Lactoferrin (rs1126478) Polymorphism and Protein Levels With Non Surgical Periodontal Therapy in Periodontitis Patients With and Without CHD
NCT07353606Periodontitis, Chronic Periodontitis (Disorder), Coronary Heart Disease
Meenakshi Ammal Dental College and Hospital
Not applicable
84
Chennai
2024-11-20
Recruiting
The Health and Social Consequences of Depression Among the Elderly
NCT05856552Depression, Functional Impairment
National Bureau of Economic Research, Inc.
Not applicable
5,370
Chennai
2024-11-20
Recruiting
EASi-KIDNEYโ„ข (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824Kidney Disease, Chronic
Boehringer Ingelheim
Phase 3
11,000
Bangalore, Bathinda, Bhubaneswar, Bilฤspur, Chandigarh, Chennai, Dwฤrka, Faridabad
2024-08-30
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883Inflammatory Bowel Diseases, Crohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Chennai, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi
2024-07-18
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288Heart Failure
Boehringer Ingelheim
Phase 3
6,000
Aurangabad, Bangalore, Bengaluru, Bikaner, Chennai, Gurgaon, Guwahati, Kochi
2024-06-17
Active, closed
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
Eli Lilly and Company
Phase 3
10,000
Allahฤbฤd, Bangalore, Bhubaneswar, Bikaner, Chennai, Dehradun, Guntur, Kanpur
2024-04-30
Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC โ‰ฅ 50%) and Without Actionable Genomic Alterations
NCT06357533Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
675
Chennai, Dwฤrka, Jaipur, Kolkata, Marg Jaipur, Nagpur, Nashik, New Delhi
2024-04-11
Active, closed
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
NCT06268873Chronic Kidney Disease and Hypertension
AstraZeneca
Phase 3
2,554
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Dehradun, Hyderabad, Kolkata
2024-03-29
Not yet open
Intensified Short Course Regimen for TBM in Adults
NCT05917340Tuberculous Meningitis
Indian Council of Medical Research
Phase 3
372
Chennai
2024-03
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT05827081Early Breast Cancer
Novartis Pharmaceuticals
Phase 3
1,400
Hyderabad, Bangalore, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai, Kolkata
2024-02-28
Recruiting
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
NCT06006559Dengue
Novartis Pharmaceuticals
Phase 2
108
Belagavi, Mumbai, Pune, Jaipur, Chennai
2024-02-20
Recruiting
V+PSF-M for Tobacco Cessation in HIV Care in India
NCT05786547Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco
University of Colorado, Denver
Phase 3
400
Chennai
2024-01-02
Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
NCT06103864Breast Cancer
AstraZeneca
Phase 3
625
Calicut, Chennai, Jaipur, Kochi, Kolkata, Kottayam, Marg Jaipur, Mohali
2023-11-23
Rows per page Showing 26–50 of 89
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/chennai

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.